Abstract: Edible compositions are provided and comprise a soluble mineral component and/or a phosphate component in amounts effective for use as an oral medicament. The soluble mineral component comprises one or more minerals selected from the group consisting of zinc, manganese, tin, copper, and mixtures thereof. The edible compositions are advantageously companion animal chews, treats or supplements. Further disclosed are methods of making the chews, treats or supplements as are methods of treating conditions of the oral cavity.

Abstract: Disclosed herein are a variety of embodiments of compositions and methods which are each adapted for use by a companion animal. In one embodiment, an edible composition comprising an amount of a soluble mineral component is disclosed, wherein the soluble mineral component comprises one or more minerals selected from the group consisting of zinc, manganese, tin, copper, and mixtures thereof, wherein the amount is an effective amount for use as an oral medicament. In further embodiments, a phosphate component is included. The edible compositions are advantageously companion animal foods or supplements. Further disclosed are methods selected from treating oral cavity tartar, oral cavity plaque, periodontal disease, gingivitis, breath odor and combinations thereof comprising orally administering a described composition to a companion animal.

Abstract: The present invention comprises a method of improving bone health and muscle health in a companion animal comprising administering a composition comprising a fatty acid component to the companion animal wherein the fatty acid component comprises a ratio of docosahexaenoic acid (DHA) to eicosapentaenoic acid (EPA) from about 3:1 to about 25:1. The present invention additionally comprises a composition comprising a fatty acid component comprising docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) wherein the ratio of docosahexaenoic acid (DHA) to eicosapentaenoic acid (EPA) is from about 3:1 to about 25:1.

Abstract: The present invention comprises a method of improving bone health and muscle health in a companion animal comprising administering a composition comprising a fatty acid component to the companion animal wherein the fatty acid component comprises a ratio of docosahexaenoic acid (DHA) to eicosapentaenoic acid (EPA) from about 3:1 to about 25:1. The present invention additionally comprises a composition comprising a fatty acid component comprising docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) wherein the ratio of docosahexaenoic acid (DHA) to eicosapentaenoic acid (EPA) is from about 3:1 to about 25:1.

Abstract: A method for determining the biological age of the companion animal. A companion animal ambulates from a first region to a second region of a pressure detection unit and the footfall data is utilized in the determination of the biological age of the companion animal.

Abstract: A management program for the benefit of a companion animal can maintain, enhance or improve the health and well-being of the companion animal. The management program can include recommendations for dietary modification, supplement administration, weight loss/management plans, physical activity recommendation, veterinary intervention and combinations thereof.

Abstract: A method for determining the biological age of the companion animal. A companion animal ambulates from a first region to a second region of a pressure detection unit and the footfall data is utilized in the determination of the biological age of the companion animal.

Abstract: A management program for the benefit of a companion animal can maintain, enhance or improve the health and well-being of the companion animal. The management program can include recommendations for dietary modification, supplement administration, weight loss/management plans, physical activity recommendation, veterinary intervention and combinations thereof.

Abstract: Presently described are compositions and methods which utilize stearidonic acid (SDA). In one embodiment, the disclosure is directed to pet food compositions comprising SDA. In optional embodiments, the compositions are nutritionally balanced compositions, or supplements. In yet another embodiment, the disclosure is directed to methods selected from promoting bone or joint health, promoting chondrocyte functioning, maintaining tissue concentration of omega-3 fatty acids, promoting tissue concentration of omega-3 fatty acids, and combinations thereof, including the like, in a pet, comprising administration of a composition comprising SDA to the pet. In optional embodiments, the pet is a puppy, kitten, large breed dog, or geriatric animal.

Abstract: Presently described are compositions and methods which utilize stearidonic acid (SDA). In one embodiment, the disclosure is directed to pet food compositions comprising SDA. In optional embodiments, the compositions are nutritionally balanced compositions, or supplements. In yet another embodiment, the disclosure is directed to methods selected from promoting bone or joint health, promoting chondrocyte functioning, maintaining tissue concentration of omega-3 fatty acids, promoting tissue concentration of omega-3 fatty acids, and combinations thereof, including the like, in a pet, comprising administration of a composition comprising SDA to the pet. In optional embodiments, the pet is a puppy, kitten, large breed dog, or geriatric animal.

Abstract: A method for increasing the hunt performance of a hunting mammal which includes orally administering to the mammal an effective amount of a diet comprising unsaturated fatty acid eicosapentaenoic acid (EPA), unsaturated fatty acid docosahexaenoic acid (DHA), or both unsaturated fatty acids, in a total amount of the diet greater than about 0.20 weight percent. The invention also provides dietary compositions that yield other beneficial results.